New research shows how H5N1 virus causes disease

H5N1 influenza, also known as avian influenza, is considered a major global threat to human health, with high fatality rates. While little had been known about the specific effects of H5N1 on organs and cells targeted by the virus, researchers at Beijing University, Columbia University Mailman School of Public Health, and SUNY Downstate report in the September 29, 2007 issue of the Lancet detailed studies of human H5N1 victims that shed light on the anatomic distribution of the virus and its pathogenesis.

Using a combination of molecular and protein labeling techniques, the authors found that H5N1 is present in the gastrointestinal tract and immune and central nervous systems, as well as the respiratory tract. In one patient, virus was transmitted across the placenta to the fetus.

The newly obtained data are important in the clinical, pathological, and epidemiological investigations of human H5N1 infection, and have widespread implications for public-health and healthcare providers. Although there has been considerable progress in studying the virus itself, and in developing surveillance networks, diagnostic tests, drugs and vaccines, only limited information has been obtained concerning the mechanisms by which H5N1 causes disease.

H5N1 infections initially seemed to be restricted to the lungs, but later reports have suggested that influenza A H5N1 could disseminate beyond the lungs. Lung damage is severe and disproportionate to the number of cells that are infected, with macrophages and T-cells targeted for infection. These latest findings indicate that lung damage is not due to virus replication alone and support the hypothesis that indirect effects, such as soluble factors known as cytokine and chemokines, are important.

According to the paper’s senior author W. Ian Lipkin, MD, director of the Center for Infection and Immunity at Columbia University Mailman School of Public Health and professor of Epidemiology, Neurology, and Pathology at Columbia, “This is the first major paper from the Beijing Infectious Disease Center, established in the aftermath of SARS by Beijing University, the Chinese Ministry of Science and Technology (the CDC of China), and the Mailman School of Public Health. The work helps us to understand H5N1’s high fatality rate, as well as serving as model for global collaboration in the field of emerging infectious diseases.”

Source: Columbia University's Mailman School of Public Health

Related stories:

Deadly bird flu virus found at German farm: EU
German authorities were culling poultry at a farm in Germany after the discovery of a case of the deadly H5N1 bird flu virus, the European Commission announced Friday.
New study determines double flu jab needed against bird flu pandemic
An international study led by University of Leicester researchers has determined that vaccination will be the best way to protect people in the event of the next influenza pandemic – but that each person would need two doses.
'Deadly dozen' reports diseases worsened by climate change
Health experts from the Wildlife Conservation Society today released a report that lists 12 pathogens that could spread into new regions as a result of climate change, with potential impacts to both human and wildlife health and global economies. Called The Deadly Dozen: Wildlife Diseases in the Age of Climate Change, the new report provides examples of diseases that could spread as a result of changes in temperatures and precipitation levels. The best defense, according to the report's authors, is a good offense in the form of wildlife monitoring to detect how these diseases are moving so health professionals can learn and prepare to mitigate their impact.
Sharp unveils new anti-bird flu air purifier
Japan's Sharp Corp. said Wednesday that it has developed an air purifier that eliminates 99.9 percent of the virulent H5N1 strain of bird flu within 10 minutes.
Booster vaccination may help with possible future avian influenza pandemic
New evidence suggests that a booster vaccination against H5N1 avian influenza given years after initial vaccination with a different strain may prove useful in controlling a potential future pandemic. The study is published in the August 1 issue of The Journal of Infectious Diseases, now available online.
Battling bird flu by the numbers
A pair of Los Alamos National Laboratory theorists have developed a mathematical tool that could help health experts and crisis managers determine in real time whether an emerging infectious disease such as avian influenza H5N1 is poised to spread globally.
Getting wise to the influenza virus' tricks
Influenza is currently a grave concern for governments and health organisations around the world. The worry is the potential for highly virulent bird flu strains, such as H5N1, to develop the ability to infect humans easily. New drugs and vaccines to halt the spread of the virus are badly needed.
New vaccine may give long-term defense against deadly bird flu and its variant forms
A new vaccine under development may provide protection against highly pathogenic bird flu and its evolving forms, according to researchers at Purdue University and the Centers for Disease Control and Prevention who discovered the new preventative drug and have tested it in mice.

News discussion:

Medicine & Health news